Matinas BioPharma Holdings Inc (MTNB AMEX) stock market data APIs
$0.7845
-0(-0%)
as of June 5, 2026
Try our APIs with
free plan!
Matinas BioPharma Holdings Inc Financial Data Overview
Price chart is built with
Anychart
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is MAT2203, an oral formulation of amphotericin B that is starting Phase 3 clinical trials for the treatment of aspergillosis and cryptococcosis, as well as prevention of invasive fungal infections in patients due to immunosuppressive therapy. It offers MAT2501, an orally administered formulation of amikacin. The company was incorporated in 2013 and is based in Bedminster, New Jersey.
Prev. Close
0.7845
Open
0.7832
High
0.8003
Low
0.754
52 wk Range
0.48-3.09
Market Cap
5 054 K
Shares Outstanding
6 406 K
EPS
-0.2999
Beta
1.619
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Matinas BioPharma Holdings Inc data using free add-ons & libraries
Get Matinas BioPharma Holdings Inc Fundamental Data
Matinas BioPharma Holdings Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -6 924 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Matinas BioPharma Holdings Inc Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-05-11
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Matinas BioPharma Holdings Inc News
New
Matinas BioPharma receives notice from NYSE
* Matinas BioPharma (NYSE: MTNB [https://seekingalpha.com/symbol/MTNB]) said [https://seekingalpha.com/pr/20462304-matinas-biopharma-receives-notice-of-non-compliance-with-nyse-american-continued-li...
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
BEDMINSTER, N.J., April 03, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (the “Company”) (NYSE American: MTNB) announced today that on April 2, 2026, it received a notice (the “No...
Matinas BioPharma Holdings, Inc. (MTNB) Restructures Amid Challenges, Focuses on Oral Antifungal MAT2203
In this article, we will be taking a look at the 15 Best Biotech Penny Stocks to Invest in Right Now. Matinas BioPharma Holdings, Inc. is one of them. Matinas BioPharma Holdings, Inc. (NYSE:MTNB) is ...
What's going on in today's session
Intrigued by the market activity one hour before the close of the markets on Monday? Uncover the key winners and losers of today's session in our insightful analysis. [topmovers] TODAY'S TOP GAINERS...
Get Matinas BioPharma Holdings Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
